|
Delayed
Australian S.E.
23:59:10 05/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.0100 AUD | 0.00% |
|
+5.26% | -33.33% |
| 08-26 | Acrux Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 08-24 | Acrux Limited Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 5.9M 4.11M 3.67M 3.42M 3.11M 5.85M 396M 41.27M 16.06M 202M 15.43M 15.09M 649M | P/E 2025 |
-0.95x | P/E 2026 | -8.4x |
|---|---|---|---|---|---|
| Enterprise Value | 6.71M 4.68M 4.17M 3.89M 3.54M 6.66M 450M 46.96M 18.27M 230M 17.55M 17.18M 739M | EV / Sales 2025 |
2.07x | EV / Sales 2026 | 1.08x |
| Free-Float |
95.6% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| ACR | Delayed | |
OTC Markets
| ARUXF | Delayed | |
Deutsche Boerse AG
| FJY | Delayed |
Last Transcript: Acrux Limited
| 23/05/22 | Acrux : Application for quotation of securities - ACR | PU |
| 14/04/22 | Acrux : Application for quotation of securities - ACR | PU |
| 15/03/22 | Acrux : Application for quotation of securities - ACR | PU |
| 25/02/22 | Acrux : Updated Board Charter | PU |
| 25/02/22 | Acrux : Application for quotation of securities - ACR | PU |
| 1 week | +5.26% | ||
| Current month | +11.11% | ||
| 1 month | -9.09% | ||
| 3 months | -16.67% | ||
| 6 months | -9.09% | ||
| Current year | -33.33% |
| 1 week | 0.01 | 0.01 | |
| 1 month | 0.01 | 0.01 | |
| Current year | 0.01 | 0.02 | |
| 1 year | 0.01 | 0.02 | |
| 3 years | 0.01 | 0.1 | |
| 5 years | 0.01 | 0.13 | |
| 10 years | 0.01 | 0.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Warmbrunn
CEO | Chief Executive Officer | - | 31/05/2025 |
Joanna Johnson
DFI | Director of Finance/CFO | - | 20/06/2021 |
Jolanta Airey
CTO | Chief Tech/Sci/R&D Officer | - | 23/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Ross Dobinson
CHM | Chairman | 74 | 31/12/2005 |
Timothy Oldham
BRD | Director/Board Member | - | 30/09/2013 |
Geoff Brooke
BRD | Director/Board Member | 70 | 31/05/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +5.26% | -33.33% | -75.61% | 4.1M | ||
| +0.02% | -3.52% | +36.11% | +111.11% | 1,019B | ||
| -1.21% | -6.99% | +34.08% | +60.96% | 617B | ||
| +1.12% | -0.20% | +13.62% | +80.24% | 464B | ||
| -3.30% | -6.15% | +56.45% | +34.69% | 356B | ||
| +0.93% | -1.83% | +21.65% | +41.43% | 333B | ||
| +0.12% | -4.05% | +10.70% | +33.53% | 267B | ||
| -0.89% | -5.83% | -7.00% | +7.91% | 244B | ||
| -0.01% | -3.62% | +35.28% | +52.02% | 218B | ||
| -0.08% | -4.98% | +28.34% | +93.61% | 179B | ||
| Average | +0.19% | -2.26% | +19.59% | +43.99% | 369.72B | |
| Weighted average by Cap. | +0.44% | -3.63% | +28.50% | +68.49% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 4.49M 3.13M 2.79M 2.6M 2.37M 4.46M 301M 31.41M 12.22M 154M 11.74M 11.49M 494M | 6.58M 4.59M 4.09M 3.81M 3.47M 6.53M 442M 46.06M 17.92M 225M 17.22M 16.85M 725M |
| Net income | -5.94M -4.14M -3.7M -3.44M -3.13M -5.9M -399M -41.61M -16.19M -204M -15.55M -15.22M -655M | -604K -421K -376K -350K -318K -600K -40.54M -4.23M -1.64M -20.69M -1.58M -1.55M -66.51M |
| Net Debt | 2.77M 1.93M 1.72M 1.61M 1.46M 2.75M 186M 19.4M 7.55M 94.96M 7.25M 7.1M 305M | 813K 567K 505K 471K 429K 807K 54.57M 5.69M 2.21M 27.85M 2.13M 2.08M 89.52M |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/10/26 | A$0.0100 | 0.00% | 5,000 |
| 05/10/26 | A$0.0100 | 0.00% | 1,401,470 |
| 02/10/26 | A$0.0100 | 0.00% | 1,392,258 |
| 01/10/26 | A$0.0100 | +11.11% | 10,907 |
| 30/09/26 | A$0.009000 | -5.26% | 1,083,094 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ACR Stock
Select your edition
All financial news and data tailored to specific country editions

















